Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor IX (FIX), commonly known as the Christmas factor, is a vitamin K-dependent serine protease that plays a crucial role in the intrinsic pathway of blood coagulation. The protein was discovered in 1952 when a young boy named Stephen Christmas was identified as lacking this clotting factor, and the discovery was published in a Christmas edition of the British Medical Journal, giving the protein its distinctive name. Factor IX functions by cleaving and activating Factor X, working in conjunction with its cofactor Factor VIII to form a membrane-bound complex that generates thrombin and ultimately leads to fibrin clot formation. Deficiency of Factor IX causes hemophilia B (Christmas disease), a rare X-linked recessive bleeding disorder that accounts for approximately 20% of all hemophilia cases. The condition results from mutations in the F9 gene, with over 3,000 variants described that affect various residues of the protein. Treatment involves recombinant Factor IX or plasma-derived Factor IX replacement therapy, which has transformed the clinical management of hemophilia B patients. A significant therapeutic challenge is the development of inhibitors to Factor IX in some patients, limiting treatment effectiveness and necessitating alternative therapeutic approaches. Additionally, Factor IX represents an attractive target for anticoagulation drugs designed to prevent thrombosis by interfering with its interactions with other coagulation factors.
Cleaves peptide bonds in Factor X, converting it to its activated form (Factor Xa). Functions as part of the intrinsic coagulation pathway feedback loop, where Factor IXa works with Factor VIIIa cofactor in a membrane-bound complex to activate Factor X. Requires calcium ions, membrane phospholipids, and Factor VIII cofactor for physiological activity. Operates through a serine protease catalytic mechanism involving a catalytic triad of Asp, His, and Ser residues.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation factor IX (F9 protein) (FIX or Factor IX).